Health economic model to evaluate the cost-effectiveness of smoking cessation services integrated within lung cancer screening in the United Kingdom
Smoking cessation interventions within lung cancer screening are cost-effective and should be integrated, so that treatment is initiated during screening visits. This is likely to reduce overall costs to the health service, and wider integrated care systems, improve quality and length of life, and may lessen health inequalities.
Authors
- Hayden Holmes (ORCID: https://orcid.org/0000-0003-2559-061X)
- S Agrawal
- Nicholas S Hopkinson (ORCID: https://orcid.org/0000-0003-3235-0454)
- M Evison
- Patrick Goodley (ORCID: https://orcid.org/0000-0002-5729-2548)
- Rachael L Murray (ORCID: https://orcid.org/0000-0001-5477-2557)
- Richard Booton (ORCID: https://orcid.org/0000-0003-4512-2899)
- Zoe Merchant (ORCID: https://orcid.org/0000-0001-6217-2973)
- Haval Balata (ORCID: https://orcid.org/0000-0002-8596-9376)
- Hazel Cheeseman (ORCID: https://orcid.org/0009-0007-6119-6405)
- P. Crosbie
- Matthew Callister (ORCID: https://orcid.org/0000-0001-8157-0803)
- David Baldwin (ORCID: https://orcid.org/0000-0001-8410-7160)
- Rebecca Naylor
- Alaa Alsaaty
- Robert Malcolm
- Matthew Taylor
Institutions
- University of Nottingham (GB)
- Action on Smoking and Health (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Manchester Academic Health Science Centre (GB)
- Glenfield Hospital (GB)
- University of Manchester (GB)
- ET Enterprises (United Kingdom) (GB)
- Manchester University NHS Foundation Trust (GB)
- UK Centre for Tobacco & Alcohol Studies (GB)
- Institute of Infection and Immunity (CA)
- Imperial College London (GB)
Publication Details
- Journal
- Thorax
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1136/thorax-2024-222815
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 36.44